Literature DB >> 26782342

Risk stratification and therapeutics of neuroblastoma: the challenges remain.

Hong Mei1, Zhen-Yu Lin2, Qiang-Song Tong3.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26782342     DOI： 10.1007/s12519-016-0001-6

Source DB:  PubMed          Journal:  World J Pediatr            Impact factor:   2.764


× No keyword cloud information.
  26 in total

1.  Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes.

Authors:  Jan J Molenaar; Jan Koster; Danny A Zwijnenburg; Peter van Sluis; Linda J Valentijn; Ida van der Ploeg; Mohamed Hamdi; Johan van Nes; Bart A Westerman; Jennemiek van Arkel; Marli E Ebus; Franciska Haneveld; Arjan Lakeman; Linda Schild; Piet Molenaar; Peter Stroeken; Max M van Noesel; Ingrid Ora; Evan E Santo; Huib N Caron; Ellen M Westerhout; Rogier Versteeg
Journal:  Nature       Date:  2012-02-22       Impact factor: 49.962

Review 2.  Recent advances in neuroblastoma.

Authors:  John M Maris
Journal:  N Engl J Med       Date:  2010-06-10       Impact factor: 91.245

3.  ALK mutations confer differential oncogenic activation and sensitivity to ALK inhibition therapy in neuroblastoma.

Authors:  Scott C Bresler; Daniel A Weiser; Peter J Huwe; Jin H Park; Kateryna Krytska; Hannah Ryles; Marci Laudenslager; Eric F Rappaport; Andrew C Wood; Patrick W McGrady; Michael D Hogarty; Wendy B London; Ravi Radhakrishnan; Mark A Lemmon; Yaël P Mossé
Journal:  Cancer Cell       Date:  2014-11-10       Impact factor: 31.743

Review 4.  At the frontier of progress for paediatric oncology: the neuroblastoma paradigm.

Authors:  Lucas Moreno; Lynley V Marshall; Andrew D J Pearson
Journal:  Br Med Bull       Date:  2013-11-07       Impact factor: 4.291

Review 5.  Children's Oncology Group's 2013 blueprint for research: neuroblastoma.

Authors:  Julie R Park; Rochelle Bagatell; Wendy B London; John M Maris; Susan L Cohn; Katherine K Mattay; Katherine M Mattay; Michael Hogarty
Journal:  Pediatr Blood Cancer       Date:  2012-12-19       Impact factor: 3.167

Review 6.  The roles of microRNAs in neuroblastoma.

Authors:  Hong Mei; Zhen-Yu Lin; Qiang-Song Tong
Journal:  World J Pediatr       Date:  2014-01-25       Impact factor: 2.764

Review 7.  Neuroblastoma.

Authors:  John M Maris; Michael D Hogarty; Rochelle Bagatell; Susan L Cohn
Journal:  Lancet       Date:  2007-06-23       Impact factor: 79.321

8.  Long noncoding RNA in neuroblastoma: new light on the (old) N-Myc story.

Authors:  Martin Pichler; George Adrian Calin
Journal:  J Natl Cancer Inst       Date:  2014-06-06       Impact factor: 13.506

9.  The long non-coding RNA Paupar regulates the expression of both local and distal genes.

Authors:  Keith W Vance; Stephen N Sansom; Sheena Lee; Vladislava Chalei; Lesheng Kong; Sarah E Cooper; Peter L Oliver; Chris P Ponting
Journal:  EMBO J       Date:  2014-02-01       Impact factor: 11.598

Review 10.  Natural killer cells and neuroblastoma: tumor recognition, escape mechanisms, and possible novel immunotherapeutic approaches.

Authors:  Cristina Bottino; Alessandra Dondero; Francesca Bellora; Lorenzo Moretta; Franco Locatelli; Vito Pistoia; Alessandro Moretta; Roberta Castriconi
Journal:  Front Immunol       Date:  2014-02-12       Impact factor: 7.561
View more
  2 in total

1.  S-trityl-L-cysteine, a novel Eg5 inhibitor, is a potent chemotherapeutic strategy in neuroblastoma.

Authors:  Wei Wu; Shao Jingbo; Weijue Xu; Jiangbin Liu; Yiming Huang; Qingfeng Sheng; Zhibao Lv
Journal:  Oncol Lett       Date:  2018-05-21       Impact factor: 2.967

2.  Armadillo repeat containing 12 promotes neuroblastoma progression through interaction with retinoblastoma binding protein 4.

Authors:  Dan Li; Huajie Song; Hong Mei; Erhu Fang; Xiaojing Wang; Feng Yang; Huanhuan Li; Yajun Chen; Kai Huang; Liduan Zheng; Qiangsong Tong
Journal:  Nat Commun       Date:  2018-07-19       Impact factor: 14.919
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.